Science Explorer Interactive view Map

Biogen (United Kingdom)

Research works
57
▲ 69% vs 2013–17
Citations
1.1k
18.9 per fractional work
Top-10% rate
20.6%
record average 16.5%
Open access
35%
world 28%

Not ranked overall: Biogen (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.30× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 10.66× its world share, 1 worksImmunology and Micro…Neuroscience: 1.26× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.19× its world share, 0 worksPharmacology, Toxico…Mathematics: 2.14× its world share, 0 worksMathematicsHealth Professions: 1.23× its world share, 0 worksHealth ProfessionsMedicine: 2.87× its world share, 7 worksMedicineEconomics, Econometrics and Finance: 7.02× its world share, 2 worksEconomics, Econometr…Social Sciences: 0.30× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 10.7×. Every wedge is a field page.

Which keywords describe research at Biogen (United Kingdom)?

By fractional works in all years, weighted toward what it does more of than the world: Diagnostic Criteria, Cognitive Impairment, Multiple Sclerosis, Neuromyelitis Optica, Monoclonal Antibodies, Quality of Life, Clinical Outcomes and Biopharmaceuticals.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Diagnostic Criteria5▲ 43×3 topics
  2. Cognitive Impairment5▲ 37×2 topics
  3. Multiple Sclerosis5▲ 253×1 topic
  4. Neuromyelitis Optica5▲ 253×1 topic
  5. Monoclonal Antibodies4▲ 52×3 topics
  6. Quality of Life4▲ 5.4×6 topics
  7. Bioanalytical Methods3▲ 385×1 topic
  8. Biopharmaceuticals3▲ 86×2 topics
  9. Biosimilars3▲ 385×1 topic
  10. Clinical Outcomes3▲ 29×2 topics
  11. Cost-effectiveness Analysis3▲ 75×1 topic
  12. Health Utility Measures3▲ 75×1 topic
  13. Immunogenicity3▲ 114×2 topics
  14. Fibrosis3▲ 24×4 topics
  15. SMN13▲ 201×1 topic
  16. Spinal Muscular Atrophy3▲ 201×1 topic
  17. Autoantibodies2▲ 19×4 topics
  18. Treatment2▲ 3.0×5 topics
  19. Clinical Trials2▲ 6.0×6 topics
  20. Diagnosis2▲ 3.5×6 topics
  21. Prognostic Factors2▲ 7.9×3 topics
  22. Genetics2▲ 4.0×3 topics
  23. TGF-ß2▲ 19×4 topics
  24. Idiopathic Pulmonary Fibrosis2▲ 78×1 topic
  25. Interstitial Lung Disease2▲ 56×1 topic
  26. Drug Development2▲ 20×2 topics
  27. Inflammatory Bowel Disease2▲ 26×3 topics
  28. Neurodegeneration2▲ 9.3×4 topics
  29. Lymphoma2▲ 18×3 topics
  30. Rheumatoid Arthritis2▲ 27×2 topics
  31. Off-Label Drug Use1▲ 65×1 topic
  32. Pediatric Pharmacokinetics1▲ 65×1 topic
  33. Acute Lymphoblastic Leukemia1▲ 62×1 topic
  34. Childhood Cancer1▲ 62×1 topic
  35. Minimal Residual Disease1▲ 35×2 topics
  36. Pregnancy1▲ 11×3 topics
  37. Renal Transplantation1▲ 43×2 topics
  38. Teratogenicity1▲ 35×2 topics
  39. Merkel Cell Carcinoma1▲ 104×1 topic
  40. Polyomavirus1▲ 104×1 topic

Which research topics does Biogen (United Kingdom) publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Biosimilars and Bioanalytical Methods, Neurogenetic and Muscular Disorders Research and Multiple Sclerosis Research Studies.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  2. 2 Biosimilars and Bioanalytical Methods Immunology 1 works
  3. 3 Neurogenetic and Muscular Disorders Research Genetics 1 works
  4. 4 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 1 works
  5. 5 Systemic Lupus Erythematosus Research Rheumatology 0 works
  6. 6 Urticaria and Related Conditions Rheumatology 0 works
  7. 7 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
  8. 8 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 0 works
  9. 9 Hematological disorders and diagnostics Emergency Medicine 0 works
  10. 10 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.1%not open64.9%

World: 28% of research is openly available.

with international co-authors68.4%domestic only31.6%

World: 19% is written across borders.

How has Biogen (United Kingdom)'s research output changed?

Output in 2018–2022 was 69% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Maidenhead

All research institutions in Maidenhead

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.